AR054381A1 - Metodo de lberacion controlada de una droga a traves de la piel - Google Patents

Metodo de lberacion controlada de una droga a traves de la piel

Info

Publication number
AR054381A1
AR054381A1 ARP060102384A ARP060102384A AR054381A1 AR 054381 A1 AR054381 A1 AR 054381A1 AR P060102384 A ARP060102384 A AR P060102384A AR P060102384 A ARP060102384 A AR P060102384A AR 054381 A1 AR054381 A1 AR 054381A1
Authority
AR
Argentina
Prior art keywords
drug
skin
solubilized
vitamin
film
Prior art date
Application number
ARP060102384A
Other languages
English (en)
Inventor
Philippe Andres
Claire Mallard
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of AR054381A1 publication Critical patent/AR054381A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Método para la liberacion controlada de una droga a través de la piel, método que comprende administrar topicamente una composicion que comprende por lo menos una droga solubilizada, una silicona formadora de película y por lo menos un solvente volátil. Reivindicacion 4: El método de acuerdo con la reivindicacion 1, caracterizado porque la composicion comprende vitamina D solubilizada o un análogo de la vitamina D. Reivindicacion 7: El método de acuerdo con la reivindicacion 1, caracterizado porque la composicion comprende un corticosteroide solubilizado. Reivindicacion 11: El método de acuerdo con la reivindicacion 1, caracterizado porque el solvente volátil es seleccionado entre el grupo que consiste en alcanoles, alquilglicoles, alquilcetonas y/o alquil ésteres en donde las partes alquilo contienen de 1 a 6 átomos de carbono. Reivindicacion 13: El método de acuerdo con la reivindicacion 1, caracterizado porque la silicona formadora de película comprende por lo menos un elastomero de poliorganosiloxano.
ARP060102384A 2005-06-10 2006-06-08 Metodo de lberacion controlada de una droga a traves de la piel AR054381A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68928205P 2005-06-10 2005-06-10

Publications (1)

Publication Number Publication Date
AR054381A1 true AR054381A1 (es) 2007-06-20

Family

ID=37137556

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102384A AR054381A1 (es) 2005-06-10 2006-06-08 Metodo de lberacion controlada de una droga a traves de la piel

Country Status (11)

Country Link
EP (1) EP1901709A2 (es)
JP (1) JP2008542423A (es)
KR (1) KR20080016612A (es)
CN (1) CN101247787B (es)
AR (1) AR054381A1 (es)
AU (1) AU2006256860B2 (es)
BR (1) BRPI0613230A2 (es)
CA (1) CA2610755A1 (es)
MX (1) MX2007015672A (es)
RU (1) RU2008100037A (es)
WO (1) WO2006131401A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
MX2009009557A (es) * 2007-03-08 2010-08-10 Crescendo Therapeutics Llc Formulaciones de aposito para prevenir o reducir la cicatrizacion.
US20100202986A1 (en) * 2007-07-11 2010-08-12 Victor Albert Raul Compositions For Delivering A Drug
EP2451280A4 (en) * 2009-07-09 2012-12-26 Crescendo Therapeutics Llc METHOD FOR WOUND HEALING AND SCALING MODULATION
MX2012007227A (es) * 2009-12-22 2012-07-30 Leo Pharma As Composicion farmaceutica que comprende analogo de vitamina d y mezcla de cosolvente-tensioactivo.
US9254296B2 (en) 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
US20160095876A1 (en) 2014-10-01 2016-04-07 Rochal Industries, Llp Composition and kits for inhibition of pathogenic microbial infection and methods of using the same
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
KR20190026397A (ko) 2017-09-05 2019-03-13 안준배 노이즈 필터링 장치 및 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
JP3251717B2 (ja) * 1992-06-29 2002-01-28 花王株式会社 皮膚外用剤
JP3573803B2 (ja) * 1994-02-16 2004-10-06 ポーラ化成工業株式会社 皮膚外用剤
KR20000064607A (ko) * 1996-03-16 2000-11-06 훽스트 악티엔게젤샤프트 손발톱건선치료용국소제제
GB9902812D0 (en) * 1998-06-18 1999-03-31 Dow Corning Sa Composition for delivering pharmaceutically active agents
WO2000072817A1 (en) * 1999-05-28 2000-12-07 Neutrogena Corporation Water-in-oil emulsion comprising a silicone gel containing vitamin c
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6365670B1 (en) * 2000-03-10 2002-04-02 Wacker Silicones Corporation Organopolysiloxane gels for use in cosmetics
DE10019128A1 (de) * 2000-04-18 2001-11-15 Wella Ag Aerosolschaum zur Haarbehandlung
US6410038B1 (en) * 2000-06-14 2002-06-25 Dow Corning Corporation Water-in-oil-in-polar solvent emulsions
DK1331927T3 (da) * 2000-10-27 2008-05-05 Leo Pharma As Topisk komposition der indeholder mindst et D-vitamin eller en D-vitamin analog og mindst et kosttikosteroid
JP2004189639A (ja) * 2002-12-09 2004-07-08 Pola Chem Ind Inc 乳化組成物
US20040228821A1 (en) * 2003-05-16 2004-11-18 The Procter & Gamble Company Personal care products comprising active agents in a gel network
EP1952808A3 (en) * 2003-11-21 2008-09-03 Galderma Research & Development Composition in the form of a spray comprising calcitriol
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile

Also Published As

Publication number Publication date
CA2610755A1 (en) 2006-12-14
WO2006131401A3 (en) 2007-03-15
WO2006131401A2 (en) 2006-12-14
AU2006256860A1 (en) 2006-12-14
RU2008100037A (ru) 2009-07-20
MX2007015672A (es) 2008-02-20
CN101247787A (zh) 2008-08-20
EP1901709A2 (en) 2008-03-26
AU2006256860B2 (en) 2012-04-19
KR20080016612A (ko) 2008-02-21
JP2008542423A (ja) 2008-11-27
CN101247787B (zh) 2011-10-05
BRPI0613230A2 (pt) 2011-01-04

Similar Documents

Publication Publication Date Title
AR054381A1 (es) Metodo de lberacion controlada de una droga a traves de la piel
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
BR112015022223A2 (pt) composições tópicas e métodos de tratamento de distúrbios tópicos
NI201000193A (es) Formulaciones orales de análogos de citidina y métodos de uso de las mismas.
AR050717A1 (es) Composiciones farmaceuticas
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
AR047928A1 (es) Derivados de tetrahidropiridoindol
CR11723A (es) Agente para tratar enfermedad
CU20060153A7 (es) Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen
UY30442A1 (es) Composiciones farmaccuticas de ropinirol, mctodos de uso, proceso de preparacinn y aplicaciones.
AR047799A1 (es) Capsula de gelatina blanda que contiene una formulacion farmaceutica con al menos un acido graso poli-insaturado omega-3
CO2019005729A2 (es) Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos
CL2011000144A1 (es) Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros.
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
BRPI0519070A2 (pt) composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
ATE492271T1 (de) Verfahren zur herstellung eines hydroxystilben- haltigen drogenextraktes
BR112015020049A8 (pt) composição na forma de uma emulsão óleo-em-água e processos cosméticos
AR046642A1 (es) Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
BR112012006010A2 (pt) composto de glicina
DE60202278D1 (de) Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten
BRPI0606373A2 (pt) composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma
DOP2009000262A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz

Legal Events

Date Code Title Description
FB Suspension of granting procedure